<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>Molecular Diversity Preservation International</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M569</article-id>
      <article-id pub-id-type="publisher-id">molbank-2008-M569</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Synthesis of 4,4'-(Cyclohexane-1,1-diyl)bis(1-methyl-1<italic>H</italic>-pyrazol-5-ol)</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Eller</surname>
            <given-names>Gernot A.</given-names>
          </name>
          <xref rid="c1-molbank-2008-M569" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Holzer</surname>
            <given-names>Wolfgang</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2008-M569">Department of Drug and Natural Product Synthesis, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria. Email: <email>gernot.eller@univie.ac.at</email>; Fax: +43-1-4277-9556</aff>
	  <author-notes>
        <corresp id="c1-molbank-2008-M569"><label>*</label>Author to whom correspondence should be addressed.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>08</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>08</month>
        <year>2008</year>
      </pub-date>
      <volume>2008</volume>
      <issue>2</issue>
      <elocation-id>M569</elocation-id>
      <history>
        <date date-type="received">
          <day>01</day>
          <month>07</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>08</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2008 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <license>
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>Methyl (2<italic>E</italic>)-3-methoxyacrylate and excess methylhydrazine yield crude 1-methyl-2-pyrazolin-5-one which is reacted with cyclohexanone to obtain the title compound in 86% yield. Detailed spectroscopic data (<sup>1</sup>H NMR, <sup>13</sup>C NMR, <sup>15</sup>N NMR, and MS) are presented.</p>
      </abstract>
      <kwd-group>
        <kwd>Pyrazolones</kwd>
		<kwd>cyclohexanone adduct</kwd>
		<kwd>NMR spectroscopy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-molbank-2008-M569" sec-type="intro">
      <title>1. Introduction</title>
      <p>During our ongoing research on pyrano[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-ones [<xref ref-type="bibr" rid="B1-molbank-2008-M569">1</xref>,<xref ref-type="bibr" rid="B2-molbank-2008-M569">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2008-M569">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2008-M569">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2008-M569">5</xref>] we were interested in the not yet commercially available methylpyrazolone <bold>1</bold>. Although dozens of patents and journal articles deal with its synthesis, most of them include multi-step reactions or seem to be less suited for laboratory scale preparations. Thus, we chose to follow a patent protocol, which starts from alkoxyacrylic alkyl esters and alkylhydrazines [<xref ref-type="bibr" rid="B6-molbank-2008-M569">6</xref>]. Recently, we have successfully applied that procedure to yield the unsubstituted pyrazolone [<xref ref-type="bibr" rid="B7-molbank-2008-M569">7</xref>]. Unfortunately, no work up for the crude methylpyrazolone <bold>1</bold> is published in the original patent (only GC/MS analysis is carried out). When we tried to find a proper solvent to precipitate the desired methylpyrazolone from the oily reaction syrup, we found that ketones &#x2013; such as acetone or cyclohexanone &#x2013; readily react and give colourless precipitates as the analysis of such a precipitate revealed. A representative procedure with cyclohexanone is presented in the experimental part [<xref ref-type="scheme" rid="molbank-2008-M569-sch001">Scheme 1</xref>].</p>
      <p>It should be noted that according to NMR data in DMSO-<italic>d</italic><sub>6</sub> solution, we presume a rather unsymmetrical conformation as outlined in <xref ref-type="scheme" rid="molbank-2008-M569-sch002">Scheme 2</xref>. Consistent with this suggestion, we achieved no intramolecular cyclization to the corresponding pyrano[2,3-<italic>c</italic>:6,5-<italic>c</italic>']dipyrazole upon treatment with conc. sulfuric acid or polyphosphoric acid, that would be expected if the hydroxy groups were spatially close.</p>
    </sec>
    <sec id="sec2-molbank-2008-M569" sec-type="methods">
      <title>2. Experimental</title>
      <p>Melting points were determined on a Reichert&#x2013;Kofler hot-stage microscope and are uncorrected. Mass spectra were obtained on a Shimadzu QP 1000 instrument (EI, 70 eV). Elemental analysis was performed at the Microanalytical Laboratory, University of Vienna. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Varian UnityPlus 300 spectrometer at 28 &#xB0;C (299.95 MHz for <sup>1</sup>H, 75.43 MHz for <sup>13</sup>C) or on a Bruker Avance 500 spectrometer at 293 K (500.13 MHz for <sup>1</sup>H, 125.77 MHz for <sup>13</sup>C). The centre of the solvent signal was used as an internal standard which was related to TMS with &#x3B4; = 7.26 ppm (<sup>1</sup>H in CDCl<sub>3</sub>), &#x3B4; = 2.49 ppm (<sup>1</sup>H in DMSO-<italic>d</italic><sub>6</sub>), &#x3B4; = 77.0 ppm (<sup>13</sup>C in CDCl<sub>3</sub>), and &#x3B4; = 39.5 ppm (<sup>13</sup>C in DMSO- <italic>d</italic><sub>6</sub>). The digital resolutions were 0.2 Hz/data point in the <sup>1</sup>H and 0.4 Hz/data point in the <sup>1</sup>H-coupled <sup>13</sup>C-NMR spectra (gated decoupling). <sup>15</sup>N NMR spectra were obtained on a Bruker Avance 500 instrument with a &#x2018;directly&#x2019; detecting broadband observe probe and were referenced against external nitromethane (coaxial capillary).</p>
      <sec id="sec2dot1-molbank-2008-M569">
        <title>2.1. 4,4'-(Cyclohexane-1,1-diyl)bis(1-methyl-1H-pyrazol-5-ol) (2)</title>
        <p><bold>CAUTION:</bold> Methylhydrazine is a potentially highly toxic compound and must be used with great care under a well-ventilated hood.</p>
        <p>To a well stirred solution of methyl 3-methoxyacrylate (50 mmol, 5.80 g) in dry MeOH (5 mL) methylhydrazine (75 mmol, 3.46 g) was added dropwise and the mixture was stirred at room temperature for 3 h. Then the excess solvent and reagents were distilled off using a rotary evaporator to obtain the crude methylpyrazolone <bold>1</bold> as a yellowish honey-like mass [<xref ref-type="bibr" rid="B9-molbank-2008-M569">9</xref>]. Cyclohexanone (25 mmol, 2.45 g) was added to the residue and the mixture was refluxed for 5 min. The formed precipitate was filtered off and washed subsequently with petroleum ether and acetone to yield the pure title compound <bold>2</bold> (5.91 g, 86%).</p>
        <p>Mp: 186&#x2013;191 &#xB0;C, colourless powder.</p>
        <p><sup>1</sup>H NMR (300 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x3B4; (ppm) 13.77 (br s, 2H, OH), 7.16 (s, 2H, pyrazole H-3), 3.38 (s, 6H, NMe), 2.07 (m, 4H, cyclohexane H-2,6), 1.38 (m, 6H, cyclohexane H-3,4,5).</p>
        <p><sup>13</sup>C NMR (75 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x3B4; (ppm) 156.0 (pyrazole C-5), 132.6 (pyrazole C-3, <sup>1</sup><italic>J</italic> = 183.8 Hz), 110.9 (pyrazole C-4), 33.5 (cyclohexane C-1), 33.2 (cyclohexane C-2,6), 31.6 (NMe, <sup>1</sup><italic>J</italic> = 140.0 Hz), 26.0 (cyclohexane C-4), 21.9 (cyclohexane C-3,5).</p>
        <p><sup>15</sup>N NMR (50 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x3B4; (ppm) &#x2013;210.0 (N-1); N-2 was not found.</p>
        <p>MS (<italic>m/z</italic>, %): 276 (M<sup>+</sup>, 3), 179 (42), 178 (100), 163 (50), 149 (34), 135 (33), 124 (28), 111 (48), 99 (26), 98 (53), 79 (36), 55 (45), 43 (46).</p>
        <p>Elemental Analysis: Calculated for C<sub>14</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub> (276.33): C, 60.85%; H, 7.30%; N, 20.28%. Found: C, 60.66%; H, 7.24%; N, 20.34%.</p>
      </sec>
    </sec>
  </body>
  <back>
   <app-group>
    <app id="app1-molbank-2008-M569">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2008-M569-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M569-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2008-M569-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M569-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
        <supplementary-material id="molbank-2008-M569-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M569-s002-mod.mol">
   <label>Supplementary File 3</label>
</supplementary-material>
<supplementary-material id="molbank-2008-M569-s004" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M569-s002.mol">
   <label>Supplementary File 4</label>
</supplementary-material>
    </app>
</app-group>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2008-M569">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Wimmer</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Haring</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>An efficient approach to heterocyclic analogues of xanthone: a short synthesis of all possible pyrido[5,6]pyrano[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-ones</article-title>
          <source>Synthesis</source>
          <year>2006</year>
          <volume>24</volume>
          <fpage>4219</fpage>
          <pub-id pub-id-type="doi">10.1055/s-2006-950324</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2008-M569">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Haring</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Datterl</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Zwettler</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Tri- and tetracyclic heteroaromatic systems: synthesis of novel benzo-, benzothieno- and thieno-fused pyrano[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-ones</article-title>
          <source>Heterocycles</source>
          <year>2007</year>
          <volume>71</volume>
          <fpage>87</fpage>
          <pub-id pub-id-type="doi">10.1002/chin.200724119</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2008-M569">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>A convenient approach to heterocyclic building blocks: synthesis of novel ring systems containing a [5,6]pyrano[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-one moiety</article-title>
          <source>Molecules</source>
          <year>2007</year>
          <volume>12</volume>
          <fpage>60</fpage>
          <pub-id pub-id-type="doi">10.3390/12010060</pub-id>
          <pub-id pub-id-type="pmid">17693953</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2008-M569">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Datterl</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Pyrazolo[4',3':5,6]pyrano[2,3-<italic>b</italic>]quinoxalin-4(1<italic>H</italic>)-one: synthesis and characterization of a novel tetracyclic ring system</article-title>
          <source>J. Heterocycl. Chem.</source>
          <year>2007</year>
          <volume>44</volume>
          <fpage>1139</fpage>
          <pub-id pub-id-type="doi">10.1002/jhet.5570440526</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2008-M569">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Wimmer</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of novel polycyclic ring systems containing two pyrano[2,3-<italic>c</italic>]pyrazol-4(1<italic>H</italic>)-one moieties</article-title>
          <source>Khim. Geterotsikl. Soedin.</source>
          <year>2007</year>
          <volume>1251</volume>
        </citation>
		 <citation citation-type="journal">
		 <source>Chem. Heterocycl. Comp.</source>
          <year>2007</year>
          <volume>43</volume>
		  <fpage>1060</fpage>
		  <pub-id pub-id-type="doi">10.1007/s10593-007-0165-z</pub-id>
		  </citation>
      </ref>
      <ref id="B6-molbank-2008-M569">
        <label>6.</label>
        <citation citation-type="patent">
          <person-group person-group-type="author">
            <name>
              <surname>Maywald</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Steinmetz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rack</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gotz</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Gotz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Henkelmann</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Aiscar Bayeto</surname>
              <given-names>J.J.</given-names>
            </name>
          </person-group>
          <article-title>Preparation of 1-substituted 5- or 3-hydroxypyrazoles from alkoxyacrylates and hydrazines</article-title>
          <source>PCT Int. Appl.</source>
          <patent>WO 0031042</patent>
          <year>2000</year>
          <comment>[<italic>Chem. Abstr.</italic>, <bold>2000</bold>, <italic>133</italic>, 4655]</comment>
        </citation>
      </ref>
      <ref id="B7-molbank-2008-M569">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>A one-step synthesis of pyrazolone</article-title>
          <source>Molbank</source>
          <year>2006</year>
          <elocation-id>M464</elocation-id>
          <comment><italic>Chem. Abstr.</italic> <bold>2006</bold>, <italic>145</italic>, 505356</comment>
          <pub-id pub-id-type="doi">10.3390/M464</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2008-M569">
        <label>8.</label>
        <citation citation-type="book">
          <article-title>ACD/3D Viewer, version 10.00</article-title>
          <publisher-name>Advanced Chemistry Development, Inc.</publisher-name>
          <publisher-loc>Toronto, ON, Canada</publisher-loc>
          <year>2006</year>
		  <comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.acdlabs.com" ext-link-type="uri">www.acdlabs.com</ext-link></comment>
        </citation>
      </ref>
	  <ref id="B9-molbank-2008-M569">
        <label>9.</label>
		<note><p>Upon trituration and subsequent recrystallization of the oily residue with/from i.e. diethyl ether, pure methylpyrazolone <bold>1</bold> can be obtained as colourless crystals. Mp 108.5&#x2013;111 &#xB0;C. <sup>1</sup>H NMR (500 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x3B4; (ppm) 10.90 (br s, 1H, OH), 7.09 (d, <sup>3</sup><italic>J</italic>(H-3,H-4) = 1.9 Hz, 1H, H-3), 5.30 (d, <sup>3</sup><italic>J</italic>(H-4,H-3) = 1.9 Hz, 1H, H-4), 3.47 (s, 3H, NMe). <sup>13</sup>C NMR (125 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x3B4; (ppm) 152.6 (C-5, <sup>2</sup><italic>J</italic>(C-5,H-4) = 5.7 Hz, <sup>3</sup><italic>J</italic>(C-5,H-3) = 10.5 Hz, <sup>3</sup><italic>J</italic>(C-5,NMe) = 1.9 Hz), 137.1 (C-3, <sup>1</sup><italic>J</italic> = 182.7 Hz, <sup>2</sup><italic>J</italic>(C-4,H-3) = 5.1 Hz), 86.1 (C-4, <sup>1</sup><italic>J</italic> = 176.1 Hz), 32.9 (NMe, <sup>1</sup><italic>J</italic> = 139.3 Hz). <sup>15</sup>N NMR (50 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x3B4; (ppm) &#x2212;201.9 (N-1); N-2 was not found.</p>
		</note>
		 </ref>
    </ref-list>
	    <fn-group>
      <fn>
        <p><italic>Sample Availability:</italic> Compounds <bold>1</bold> and <bold>2</bold> are available from MDPI.</p>
      </fn>
    </fn-group>    
    <sec sec-type="display-objects">
      <title>Schemes</title>
      <fig id="molbank-2008-M569-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2008-M569-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of the title compound <bold>2</bold></p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M569-sch001.tif"/>
      </fig>
      <fig id="molbank-2008-M569-sch002" position="float">
        <object-id pub-id-type="pii">molbank-2008-M569-sch002_Scheme 2</object-id>
        <label>Scheme 2</label>
        <caption>
          <p>Proposed conformation of compound <bold>2</bold> in DMSO solution [<xref ref-type="bibr" rid="B8-molbank-2008-M569">8</xref>]</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2008-M569-sch002.tif"/>
      </fig>
    </sec>
  </back>
</article>
